Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Embla Medical hfOSSFF 92 3-Year Book Growth Rate is 7.70% as of Jun. 2026, which is 25% below its 10-year median of 10.20. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $4.90. Among 763 Medical Devices & Instruments companies, Embla Medical hf ranks better than 68.15% on this metric.
During the past 12 months, Embla Medical hf's average Book Value per Share Growth Rate was 11.00% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 7.70% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 9.90% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 6.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Embla Medical hf was 47.10% per year. The lowest was 4.10% per year. And the median was 10.20% per year.
Embla Medical hf (OTCPK:OSSFF) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Embla Medical hf 3-Year Book Growth Rate Related Terms
OSSFF vs ABT, SYK, MDT: 3-Year Book Growth Rate Comparison
For the Medical Devices subindustry, Embla Medical hf's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf 3-Year Book Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's 3-Year Book Growth Rate falls into.
Embla Medical hf 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 7.70% mean?
Embla Medical hf (OSSFF) has a 3-Year Book Growth Rate of 7.70% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Embla Medical hf and its competitors. This is 25% below median its historical median of 10.20. Over the past decade, Embla Medical hf's 3-Year Book Growth Rate has ranged from 4.10 to 47.10. According to the industry distribution chart, Embla Medical hf ranks #243 out of 763 companies in the Medical Devices & Instruments industry, placing it in the top 31.8%.
Is Embla Medical hf's 3-Year Book Growth Rate too high?
Embla Medical hf's current 3-Year Book Growth Rate of 7.70% is 25% below median its 10-year median of 10.20. Over the past 10 years, this metric has ranged from a low of 4.10 to a high of 47.10. The Medical Devices & Instruments industry median 3-Year Book Growth Rate is 2.30. Embla Medical hf's value of 7.70% is 234.8% above this industry median. Based on the distribution chart, Embla Medical hf ranks #243 out of 763 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's 3-Year Book Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #243 out of 763 companies for 3-Year Book Growth Rate. This puts Embla Medical hf in the upper half of its industry. The industry median 3-Year Book Growth Rate is 2.30. Embla Medical hf's value of 7.70% is 234.8% above this benchmark. Historically, Embla Medical hf's own 3-Year Book Growth Rate has ranged from 4.10 to 47.10 over the past decade. While the company's 10-year median is 10.20 vs. the industry median of 2.30, Embla Medical hf has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Book Growth Rate among Medical Devices & Instruments companies is 2.30, based on 763 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current 3-Year Book Growth Rate of 7.70% is 234.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Book Growth Rate is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current 3-Year Book Growth Rate is 7.70%, which is 25% below median its own 10-year median of 10.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current 3-Year Book Growth Rate of 7.70%. The stock's GF Value™ is $4.90, compared to a current price of $4.15 — trading 15.3% below its estimated fair value. The current 3-Year Book Growth Rate is 7.70%, which is 25% below median its 10-year median of 10.20 and 234.8% above the Medical Devices & Instruments industry median of 2.30. Embla Medical hf's overall GF Score™ is 92/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current 3-Year Book Growth Rate is 7.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 15.3% below its estimated GF Value™ of $4.90.
Key valuation signals for OSSFF:
3-Year Book Growth Rate: 7.70% (25% below median its 10-year median of 10.20)
GF Value™: $4.90 vs. price of $4.15 (15.3% below fair value)
Industry Position: 234.8% above the Medical Devices & Instruments median (#243 of 763)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OSSFF
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
